2023年报业绩点评:业绩大幅提升,IL-17年底提交上市申请
Sunshine Guojian Pharmaceutical(688336) 国泰君安·2024-03-24 16:00
证 券 研 究 报 告 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------|-----------------------------------------------------------------------|----------------------------------|----------------------------|----------------------------------------------------------------------------------|----------------------|-------------------------|---------------------------------------------|------------|-----------------| | [Table_MainInfo] \n [Table_Title] 三生国健 | (6 ...